vs

Side-by-side financial comparison of ARBOR REALTY TRUST INC (ABR) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

ARBOR REALTY TRUST INC is the larger business by last-quarter revenue ($133.4M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -12.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -8.9%).

Arbor Realty Trust Inc. is a U.S.-headquartered specialized real estate investment trust (REIT). It primarily provides structured financing solutions for multifamily residential and commercial real estate projects, including bridge loans, agency lending, and mezzanine financing. Its core market covers the U.S. real estate sector, serving property owners, developers and real estate investors nationwide.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

ABR vs PRCT — Head-to-Head

Bigger by revenue
ABR
ABR
1.6× larger
ABR
$133.4M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+32.3% gap
PRCT
20.2%
-12.1%
ABR
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-8.9%
ABR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ABR
ABR
PRCT
PRCT
Revenue
$133.4M
$83.1M
Net Profit
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
Revenue YoY
-12.1%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.08
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABR
ABR
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$133.4M
$76.4M
Q3 25
$112.4M
$83.3M
Q2 25
$130.4M
$79.2M
Q1 25
$134.2M
$69.2M
Q4 24
$151.7M
$68.2M
Q3 24
$156.7M
$58.4M
Q2 24
$153.1M
$53.4M
Net Profit
ABR
ABR
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$52.0M
$-21.4M
Q2 25
$36.3M
$-19.6M
Q1 25
$43.4M
$-24.7M
Q4 24
$-18.9M
Q3 24
$73.5M
$-21.0M
Q2 24
$61.8M
$-25.6M
Gross Margin
ABR
ABR
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
ABR
ABR
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-50.3%
Net Margin
ABR
ABR
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
46.3%
-25.7%
Q2 25
27.8%
-24.7%
Q1 25
32.3%
-35.8%
Q4 24
-27.6%
Q3 24
46.9%
-35.9%
Q2 24
40.4%
-48.0%
EPS (diluted)
ABR
ABR
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.08
$-0.54
Q3 25
$0.20
$-0.38
Q2 25
$0.12
$-0.35
Q1 25
$0.16
$-0.45
Q4 24
$0.31
$-0.34
Q3 24
$0.31
$-0.40
Q2 24
$0.25
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABR
ABR
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$482.9M
$245.6M
Total DebtLower is stronger
$11.1B
$51.7M
Stockholders' EquityBook value
$3.0B
$347.7M
Total Assets
$14.5B
$487.1M
Debt / EquityLower = less leverage
3.75×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABR
ABR
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$482.9M
$286.5M
Q3 25
$423.4M
$294.3M
Q2 25
$255.7M
$302.7M
Q1 25
$308.8M
$316.2M
Q4 24
$503.8M
$333.7M
Q3 24
$687.5M
$196.8M
Q2 24
$737.5M
$214.1M
Total Debt
ABR
ABR
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$11.1B
$51.6M
Q3 25
$10.4B
$51.6M
Q2 25
$10.1B
$51.5M
Q1 25
$9.9B
$51.5M
Q4 24
$10.0B
$51.5M
Q3 24
$10.3B
$51.4M
Q2 24
$10.6B
$51.4M
Stockholders' Equity
ABR
ABR
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$3.0B
$365.9M
Q3 25
$3.0B
$380.3M
Q2 25
$3.0B
$385.8M
Q1 25
$3.0B
$389.2M
Q4 24
$3.0B
$402.2M
Q3 24
$3.0B
$241.2M
Q2 24
$3.1B
$251.8M
Total Assets
ABR
ABR
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$14.5B
$508.1M
Q3 25
$13.9B
$511.5M
Q2 25
$13.6B
$513.1M
Q1 25
$13.4B
$519.4M
Q4 24
$13.5B
$534.0M
Q3 24
$13.9B
$374.1M
Q2 24
$14.2B
$374.4M
Debt / Equity
ABR
ABR
PRCT
PRCT
Q1 26
0.15×
Q4 25
3.75×
0.14×
Q3 25
3.47×
0.14×
Q2 25
3.40×
0.13×
Q1 25
3.29×
0.13×
Q4 24
3.29×
0.13×
Q3 24
3.40×
0.21×
Q2 24
3.47×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABR
ABR
PRCT
PRCT
Operating Cash FlowLast quarter
$372.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABR
ABR
PRCT
PRCT
Q1 26
Q4 25
$372.4M
$-10.3M
Q3 25
$178.7M
$-6.6M
Q2 25
$60.0M
$-15.0M
Q1 25
$150.5M
$-17.0M
Q4 24
$461.5M
$-32.4M
Q3 24
$85.0M
$-18.8M
Q2 24
$69.9M
$-15.7M
Free Cash Flow
ABR
ABR
PRCT
PRCT
Q1 26
Q4 25
$-12.2M
Q3 25
$-9.5M
Q2 25
$-17.8M
Q1 25
$-18.8M
Q4 24
$-33.6M
Q3 24
$-19.0M
Q2 24
$-16.8M
FCF Margin
ABR
ABR
PRCT
PRCT
Q1 26
Q4 25
-15.9%
Q3 25
-11.4%
Q2 25
-22.5%
Q1 25
-27.2%
Q4 24
-49.2%
Q3 24
-32.6%
Q2 24
-31.4%
Capex Intensity
ABR
ABR
PRCT
PRCT
Q1 26
Q4 25
2.4%
Q3 25
3.4%
Q2 25
3.5%
Q1 25
2.7%
Q4 24
1.7%
Q3 24
0.4%
Q2 24
2.0%
Cash Conversion
ABR
ABR
PRCT
PRCT
Q1 26
Q4 25
Q3 25
3.44×
Q2 25
1.65×
Q1 25
3.47×
Q4 24
Q3 24
1.16×
Q2 24
1.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABR
ABR

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons